Page last updated: 2024-09-05

sb 203580 and Cacosmia

sb 203580 has been researched along with Cacosmia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gao, X; Li, N; Zhang, J	1

Other Studies

1 other study(ies) available for sb 203580 and Cacosmia

Article	Year
SB203580, a p38MAPK inhibitor, attenuates olfactory dysfunction by inhibiting OSN apoptosis in AR mice (activation and involvement of the p38 mitogen-activated protein kinase in olfactory sensory neuronal apoptosis of OVA-induced allergic rhinitis). Brain and behavior, 2019, Volume: 9, Issue:6 Topics: Animals; Apoptosis; Female; Imidazoles; Irritants; MAP Kinase Signaling System; Mice, Inbred BALB C; Olfaction Disorders; Olfactory Receptor Neurons; Ovalbumin; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Pyridines; Rhinitis, Allergic; Signal Transduction; Smell	2019

Article

Year

SB203580, a p38MAPK inhibitor, attenuates olfactory dysfunction by inhibiting OSN apoptosis in AR mice (activation and involvement of the p38 mitogen-activated protein kinase in olfactory sensory neuronal apoptosis of OVA-induced allergic rhinitis).

Brain and behavior, 2019, Volume: 9, Issue:6

Topics: Animals; Apoptosis; Female; Imidazoles; Irritants; MAP Kinase Signaling System; Mice, Inbred BALB C; Olfaction Disorders; Olfactory Receptor Neurons; Ovalbumin; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Pyridines; Rhinitis, Allergic; Signal Transduction; Smell

2019